Labshake search
Citations for Tocris :
51 - 100 of 701 citations for 7 2 METHYLPHENYL 7 OXOHEPTANOIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... Day 7: proliferation was inhibited with an overnight 10 μM floxuridine (Tocris) -treatment ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, Tocris, Minneapolis, MN, USA) and d-(−)-2-amino-5-phosphonopentanoic acid (APV ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2023Quote: ... 1 μM 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate (Tocris Bioscience) was added to the culture media for glutamate uncaging.
-
bioRxiv - Neuroscience 2023Quote: ... 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt, Tocris®); Tetrodotoxin (TTX ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Cell Biology 2021Quote: ... Calcium-like peptide 2 (CALP2) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) were obtained from Tocris (Minneapolis, MN). CaM kinase II and calcineurin inhibitors ...
-
bioRxiv - Neuroscience 2019Quote: ... 4-methoxy-7-nitroindolinyl-caged L-glutamate (MNI-glutamate) were purchased from Tocris Cookson (UK) ...
-
bioRxiv - Neuroscience 2020Quote: ... 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX, Tocris) and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460 ...
-
bioRxiv - Neuroscience 2020Quote: NBQX (2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) from Tocris CGP-55845 ((2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydro xypropyl](phenylmethyl)phosphinic acid hydrochloride ...
-
bioRxiv - Neuroscience 2023Quote: ... Inhibitor cocktail containing 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris, 10 μM), (2R)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2023Quote: ... MNI-glutamate (4 methoxy-7-nitroindolinyl caged L-glutamate) was purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, 10 μM; Tocris), and D-2-amino-5-phosphonopetanoate (D-AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... 4-methoxy-7-nitroindoline-caged L-glutamate (MNI- caged-glutamate, 2.5 mM, Tocris Bioscience) was added to the bath solution ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 100µM of 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI glutamate, Tocris Bioscience).
-
bioRxiv - Neuroscience 2020Quote: ... or 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate (MNI-glutamate; 2.5 mM; Tocris), or 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate trifluoroacetate (MNI-glutamate•TFA ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris). Each epoch of the BQA experiment contains a stable segment of 28 up to 42 unitary IPSCs (mean 32.75 ± 4.15) ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris), 10 μM 4-(N-Ethyl-N-phenylamino)-1,2 dimethyl-6-(methylamino ...
-
bioRxiv - Neuroscience 2024Quote: 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) was purchased from Tocris Bioscience (1490) ...
-
bioRxiv - Biochemistry 2023Quote: ... 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN) CAS number:1428-67-7 (Tocris, Madrid, Spain) and collagenase (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2019Quote: ... pH 7.4) supplemented with 25 μM 6-cyano-7-nitroquinoxaline-2,3-dione / CNQX (Tocris Bioscience) and 50 μM D,L-2-amino-5-phosphonovaleric acid / AP5 (Tocris Bioscience) ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX disodium salt; Cat. No. 1045, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5 ...
-
bioRxiv - Neuroscience 2022Quote: ... Two-photon uncaging of 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate (2.5 mM; Tocris) was performed using a 4 ms pulse at 720 nm and ~30mW on sample (Araya et al. ...
-
bioRxiv - Neuroscience 2019Quote: ... Two-photon uncaging of 4-methoxy-7-nitroindolinyl (MNI)-caged L-glutamate (2.5 mM; Tocris) was performed as previously described67 ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris Bioscience, Briston, UK) and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Cell Biology 2021Quote: ... CBA (4-chloro-2-[[2-(2-chlorophenoxy) acetyl aminobenzoic acid from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Biochemistry 2021Quote: ... neurons at DIV 7 were made quiescent by 1 μM tetrodotoxin (TTX; 1078, Tocris, Minneapolis, MN) overnight ...
-
bioRxiv - Microbiology 2022Quote: NADA (3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride) was synthesized by Tocris following the published protocol (31) ...
-
bioRxiv - Neuroscience 2022Quote: ... we used 100 μM 4-methoxy-7-nitroindolinyl-caged-L-glutamte (MNI-glutamate, Tocris, UK, 1490) with 10 μM glycine ...
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2023Quote: Glutamate was photolysed from MNI-Glutamate (4-Methoxy-7-nitroindolinyl-caged-L-glutamate; Tocris Biotechne, UK) with a 405 nm laser (Obis ...
-
bioRxiv - Neuroscience 2022Quote: ... ascorbic acid (2 mM, Tocris Bioscience, 4055). Medium was passed through a 0.22-µm filter ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Cancer Biology 2022Quote: Pancreatitis was induced by 7 intraperitoneal injections of cerulein (50 μg/kg; Tocris Bioscience, cat#62-641) at hourly intervals on two alternating days ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 (gabazine) and 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Neuroscience 2023Quote: ... (S)-2-Amino-2-methyl-4-phosphonobutanoic acid (MAP4; 250 µM; Tocris, Item# 0711), Tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2019Quote: ... D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) and STR were added to the bath solution to block AMPA ...
-
bioRxiv - Cell Biology 2021Quote: ... L-2-amino-5-phosphonovaleric acid (AP5, Tocris Bioscience) were included in the bath solution to prevent recurrent activities.
-
bioRxiv - Neuroscience 2022Quote: ... and d-(−)-2-amino-5-phosphonopentanoic acid (APV, Tocris) were added to the ACSF ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μM Retinoic acid (Cat. No. 0695, Tocris Bioscience) and 0.25 μM LDN193189 (Cat ...